Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Historically, neoadjuvant chemotherapy (NACT) was extrapolated from adjuvant regimens. Dual HER2 blockade and the introduction of carboplatin for triple negative breast cancers (TNBC) emerged by December 2013 and have improved pathological complete response (pCR) rates. The objective of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: McFarland, Daniel C., Naikan, Jessica, Rozenblit, Mariya, Mandeli, John, Bleiweiss, Ira, Tiersten, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921638/
https://www.ncbi.nlm.nih.gov/pubmed/27382369
http://dx.doi.org/10.1155/2016/4324863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921638/
https://www.ncbi.nlm.nih.gov/pubmed/27382369
http://dx.doi.org/10.1155/2016/4324863

Ejemplares similares